All news from Nuclear Medicine

Nuclear medicine

Kids With Brain Tumors if Treated With Proton Therapy

A comparison of three types of radiotherapy for children’s brain tumours suggests that a type of proton therapy called pencil beam scanning offers the best hope of preserving cognitive functions. The study, presented at the ESTRO 38 conference, shows that this new form of radiotherapy delivers the lowest doses of radiation to the temporal lobes and hippocampus,…

Nuclear medicine

The Lower Limbs During Walking Measured Using FDG-PET

This study aimed to elucidate whether muscle activity (in terms of glucose uptake) between the legs can be considered symmetrical during walking. Furthermore; we aimed to determine whether the [ 18F]-fluorodeoxyglucose is distribute heterogeneously throughout each muscle, and if so, whether areas of high uptake would be cluster. Ten healthy participants walked on a treadmill…

MRI

Fundamentally New MRI Method Developed To Measure Brain Function

The speed of the human brain is remarkable in a fraction of a second, neurons are activated, propagating thoughts and reactions to stimuli. But the speed at which we can noninvasively follow brain function using an MRI is not as impressive. Functional MRI (fMRI), which measures changes in blood oxygen levels, has revolutionized the field…

Thyroid Diseases

Role of PET/CT in the Management of the Autoimmune Thyroid Diseases

It is a well-known fact that positron emission tomography (PET) is an effective tool in the assessment of thyroid focal lesions, however only few studies so far have investigated its role in monitoring of autoimmune thyroid diseases (AITDs). The aim of this study was to assess if PET scan may be useful for the assessment of the thyroid gland…

Nuclear medicine

Colorectal Carcinoma Clinical Practice Guidelines

The updated recommendations on the radiologic diagnosis and treatment of colorectal carcinoma (CRC) were released in April 2019 by the Association of the Scientific Medical Societies, German Cancer Society, and the German Cancer Aid. Asymptomatic patients should not undergo computed tomography (CT) colonography and magnetic resonance (MR) colonography for colon cancer protection/early detection. Colonography for colon…

Nuclear medicine

Protein 1 in Patients With Nonsmall Cell Lung Cancer:

Nuclear Yes-associated protein 1 (YAP1) has often been regarded as an adverse prognostic indicator in various tumors. Recent studies have associated YAP1 with unfavorable prognosis in nonsmall cell lung cancer (NSCLC). However, due to small sample sizes, the prognostic value of nuclear YAP1 in NSCLC patients is not well understand. Because In the present study,…

Nuclear medicine

Routine PET/CT not Beneficial for Node Negative Patients

Routine use of positron emission tomography/computed tomography prior to radical cystectomy is unlikely to benefit clinically node-negative patients;L results of a recent investigation suggest. Instead, the primary role of PET/CT appears to be further evaluation of enlarged nodes identified by CT; according to the study authors, who looked at the diagnostic properties of PET/CT in…

Radiation Theranostics

New Radiation Theranostics And Novel RIB-Based Radiolanthanoid

Cancer together with cardiovascular diseases is one of the two most prominent causes for morbidity that burden healthcare systems worldwide. In cancer, the primary tumor is often accompanied by metastases rendering the treatment very complicated. Targeted cancer therapy has, therefore, evolved to provide a mode of therapy; with a high precision and broad applicability enabled…

Nuclear medicine

PET Integrated With Computed Tomography in Carcinoma of the Cervix

To determine the impact of FDG-PET/CT in the initial staging of cervical cancer among women with and without HIV and to determine the abilities of FDG-PET/CT metabolic parameters in predicting the presence of distant metastasis We reviewed the FDG-PET/CT images of women with FIGO stage IB2 to IVA carcinoma of the cervix. We compared the…

Nuclear medicine

PET/CT Radiotracer Benefits Clinicians, Prostate Cancer Patients

18F-DCFPyL PSMA PET/CT imaging accurately localized biochemically recurrent prostate cancer and prompted clinicians to change their management plans in more than 80% of patients, according to a recent study in the Journal of Nuclear Medicine. A change in treatment occurred in more than 60% of patients. Prostate cancer accounts for one-third of male cancer deaths in Canada; but…

Nuclear medicine

The Impact of PET/CT and PET/MRI on the Management of Prostate Cancer

Prostate-specific-membrane-antigen (PSMA) is a trans membrane protein with significantly increase expression in the cells and metastases of prostate carcinoma (PCa). PSMA-expression correlates with higher serum levels of prostate-specificantigen (PSA) and a higher Gleason Score (GS). This finding has led to the development of novel imaging modalities such as 68Ga-/18F-labeled PSMA PET/CT and PET/MRI. Higher Serum…

Nuclear medicine

Glucose Uptake in Men and Women Imaged With 18F-FDG PET-CT.

Cohort studies show that cognitive dysfunction and both vascular and Alzheimer’s dementia are more common in patients with type 2 diabetes mellitus (T2DM)To review and compare brain volume and 18F-fluorodeoxyglucose (FDG) uptake in brain of individuals age 60 to 70 years with or without type 2 diabetes.We searched 620 medical records for negative 18FDG PET-CT…